An Injectable Thiol-Acrylate Poly(Ethylene Glycol) Hydrogel for Sustained Release of Methylprednisolone Sodium Succinate
Biomaterials 32 (2011) 587e597 Contents lists available at ScienceDirect Biomaterials journal homepage: www.elsevier.com/locate/biomaterials An injectable thiol-acrylate poly(ethylene glycol) hydrogel for sustained release of methylprednisolone sodium succinate Christopher D. Pritchard a,*, Timothy M. O’Shea b, Daniel J. Siegwart a, Eliezer Calo c, Daniel G. Anderson a, Francis M. Reynolds d, John A. Thomas e, Jonathan R. Slotkin e, Eric J. Woodard f, Robert Langer a,b a Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA b Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA c Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA d InVivo Therapeutics Corporation, Cambridge, MA 02142, USA e Department of Neurosurgery, The Washington Brain and Spine Institute, Washington, DC 20010, USA f Department of Neurosurgery, New England Baptist Hospital, Cambridge, MA 02120, USA article info abstract Article history: Clinically available injectable hydrogels face technical challenges associated with swelling after injection Received 4 August 2010 and toxicity from unreacted constituents that impede their performance as surgical biomaterials. To Accepted 27 August 2010 overcome these challenges, we developed a system where chemical gelation was controlled by Available online 28 September 2010 a conjugate Michael addition between thiol and acrylate in aqueous media, with 97% monomer conversion and 6 wt.% sol fraction. The hydrogel exhibited syneresis on equilibration, reducing to 59.7% Keywords: of its initial volume. It had mechanical properties similar to soft human tissue with an elastic modulus of Cell adhesion 189.8 kPa.
[Show full text]